Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2001 1
2005 1
2020 2
2022 5
2023 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL. Rindi G, et al. Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16. Endocr Pathol. 2022. PMID: 35294740 Review.
Using a question-and-answer approach, we discuss the consolidation of the nomenclature that distinguishes neuronal paragangliomas from epithelial neoplasms, which are divided into well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine car …
Using a question-and-answer approach, we discuss the consolidation of the nomenclature that distinguishes neuronal paragangliomas fro …
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Mete O, et al. Endocr Pathol. 2022 Mar;33(1):90-114. doi: 10.1007/s12022-022-09704-6. Epub 2022 Mar 13. Endocr Pathol. 2022. PMID: 35285002 Review.
Paragangliomas have a well-formed network of sustentacular cells that express SOX10 and S100, but this is not a distinctive feature, as other epithelial NENs also have sustentacular cells. Indeed, it is the presence of such cells and the association with ganglion ce …
Paragangliomas have a well-formed network of sustentacular cells that express SOX10 and S100, but this is not a distinctive fe …
Paraganglioma of the cauda equina: A clinicopathologic study of 12 cases with demonstration of cytokeratin positivity.
Zhang Y, Du Z, Xiong J, Wang Y, Yin B. Zhang Y, et al. Ann Diagn Pathol. 2022 Apr;57:151887. doi: 10.1016/j.anndiagpath.2021.151887. Epub 2022 Jan 3. Ann Diagn Pathol. 2022. PMID: 35033938
Paragangliomas are rare neuroendocrine tumors originating from neural crest-derived paraganglion cells. Primary cauda equina paraganglioma (CEP) pose both diagnostic and surgical challenges. We report 12 cases of CEP to characterize the diagnostic and …
Paragangliomas are rare neuroendocrine tumors originating from neural crest-derived paraganglion cells. Primary cauda equin …
Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F, Leboutet MJ, Petit B, Paraf F, Boncoeur-Martel MP, Moreau JJ, Catanzano G. Labrousse F, et al. Clin Neuropathol. 1999 Jul-Aug;18(4):208-13. Clin Neuropathol. 1999. PMID: 10442464
BACKGROUND: Paragangliomas rarely involve the cauda equina region. In this location, these tumors can show misleading morphological features such as trabecular or papillary growth patterns and variable expression of cytokeratins. METHODS: We com …
BACKGROUND: Paragangliomas rarely involve the cauda equina region. In this location, these tumors can show misleading m …
SDH-B, INSM1, and GATA3 expression in cauda equina neuroendocrine tumors: report on 21 cases from a North indian tertiary care center.
Sood R, Chatterjee D, Bhardwaj S, Singla N, Ahuja C, Radotra B. Sood R, et al. Hum Pathol. 2023 Jul;137:18-24. doi: 10.1016/j.humpath.2023.04.011. Epub 2023 Apr 24. Hum Pathol. 2023. PMID: 37100233
Primary neuroendocrine tumors (NETs) of the central nervous system are rare, primarily seen in the cauda equina region, known as cauda equina NETs. This study was carried out to evaluate the morphological and immunohistochemical characteristics of c …
Primary neuroendocrine tumors (NETs) of the central nervous system are rare, primarily seen in the cauda equina region, known …
Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
Asa SL, Mete O, Schüller U, Ramani B, Mirchia K, Perry A. Asa SL, et al. Am J Surg Pathol. 2023 Apr 1;47(4):469-475. doi: 10.1097/PAS.0000000000002009. Epub 2022 Dec 22. Am J Surg Pathol. 2023. PMID: 36543154
The tumor formerly known as "cauda equina paraganglioma" was recently renamed as cauda equina neuroendocrine tumor (CENET) based on distinct biological and genetic properties. ...In addition to INSM1, chromogranin, synaptophysin, and keratins …
The tumor formerly known as "cauda equina paraganglioma" was recently renamed as cauda equina neuroendocr …
The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
Ramani B, Gupta R, Wu J, Barreto J, Bollen AW, Tihan T, Mummaneni PV, Ames C, Clark A, Oberheim Bush NA, Butowski N, Phillips D, King BE, Bator SM, Treynor EC, Zherebitskiy V, Quinn PS, Walker JB, Pekmezci M, Sullivan DV, Hofmann JW, Sloan EA, M Chang S, Berger MS, Solomon DA, Perry A. Ramani B, et al. Acta Neuropathol. 2020 Dec;140(6):907-917. doi: 10.1007/s00401-020-02221-y. Epub 2020 Sep 6. Acta Neuropathol. 2020. PMID: 32892244 Free PMC article.
Up to 40% occur in the setting of a hereditary syndrome, most commonly due to germline mutations in succinate dehydrogenase (SDHx) genes. Immunohistochemically, paragangliomas are characteristically GATA3-positive and cytokeratin-negative, with loss of SDHB expre …
Up to 40% occur in the setting of a hereditary syndrome, most commonly due to germline mutations in succinate dehydrogenase (SDHx) genes. Im …
Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
Mamilla D, Manukyan I, Fetsch PA, Pacak K, Miettinen M. Mamilla D, et al. Hum Pathol. 2020 Sep;103:72-82. doi: 10.1016/j.humpath.2020.07.010. Epub 2020 Jul 12. Hum Pathol. 2020. PMID: 32668278 Free PMC article.
Duodenal gangliocytic PGLs (n = 9) and all cauda equina PGLs (n = 3) expressed keratins, lacked GATA3, showed no or minimal TH expression as some NETs, and contained SOX10 and S100 protein-positive spindle cells negative for GFAP. ...We conclude …
Duodenal gangliocytic PGLs (n = 9) and all cauda equina PGLs (n = 3) expressed keratins, lacked GATA3, showed no …
Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
Soukup J, Manethova M, Kohout A, Soukup T, Dvorakova R, Drugda J, Vitovcova B, Gabalec F, Kaiser M, Kanta M, Kasparova P, Kozak J, Michnova L, Netuka D, Reguli S, Rychly B, Trnkova M, Vachata P, Wozniakova M, Cesak T. Soukup J, et al. Virchows Arch. 2023 Feb;482(2):325-338. doi: 10.1007/s00428-022-03441-1. Epub 2022 Nov 8. Virchows Arch. 2023. PMID: 36348031
Cauda equina neuroendocrine tumors (CENETs) are neoplasms of uncertain histogenesis with overlapping features between those of paragangliomas (PGs) and visceral neuroendocrine tumors (NETs). ...We observed no loss of SDHB. Cytokeratin expression …
Cauda equina neuroendocrine tumors (CENETs) are neoplasms of uncertain histogenesis with overlapping features between those of …
14 results